Skip to main content
. 2018 Oct 15;5:2054358118804838. doi: 10.1177/2054358118804838

Figure 2.

Figure 2.

Percentage of patients in the Southern Alberta cohort hospitalized with heart failure receiving an ACE-I/ARB at varying times before and after hospital admission, according to discharge eGFR.

Note. ACE-I = angiotensin-converting enzyme inhibitors; ARB = angiotensin receptor blockers; eGFR = estimated glomerular filtration rate.